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Background: Epidemiological data associates low magnesium (Mg) intake with 
greater risk of metabolic syndrome/diabetes, and Mg status is often compromised in 
diabetic patients. It remains unclear whether low Mg consumption may exacerbate the 
metabolic disruptions that occur during diabetes.  
Objective: We hypothesized low dietary Mg during the development of diabetes 
would alter metabolic rate, and worsen glucose tolerance/insulin sensitivity.  
Methods: Three cohorts (n = 8 each) of 8-week-old TallyHo (TH) mice that 
develop Type 2 Diabetes by 16 weeks of age were fed special diets for 8 weeks. Group 1: 
TH + Low Mg diet (L-Mg, 100mg Mg Oxide/kg chow). Group 2: TH + Standard Mg diet 
(S-Mg, 500mg Mg Oxide/kg chow). Group 3: TH + High Mg diet (H-Mg, 1000mg Mg 
Bisglycinate/kg chow). Age-matched male C57BL/6J mice fed standard diets served as 
controls (Con, n = 8, 500mg Mg Oxide/kg chow).  
Results: Energy expenditure was lowest (p < 0.05) in L-Mg vs. all other groups. 
Insulin tolerance test (AUC, glucose mg/dL), indicated insulin resistance (p < 0.05) in L-
Mg (12394 ± 2344) vs. Con (3866 ± 2344), and a trend (p = 0.052) indicating greater 
insulin resistance in S-Mg (10429 ± 2193) vs. Con. However, insulin tolerance was 
normalized in H-Mg (7838 ± 2344) vs. Con. QUICKI index indicated that all groups 
were insulin resistant (p < 0.05) compared to Con (0.585 ± 0.14). However, L-Mg (0.403 
 iv 
± 0.15) had greater (p < 0.05) insulin resistance than S-Mg (0.462 ± 0.17) and H-Mg 
(0.454 ± 0.15). Insulin stimulated phosphorylation of hepatic insulin receptor was similar 
among all groups, whereas Akt phosphorylation was reduced (p < 0.05) in all diabetic 
mice regardless of Mg intake.  
Conclusions: Low dietary Mg intake reduces oxygen consumption and energy 
expenditure, and worsens insulin sensitivity in diabetic mice. Supplemental Mg can 
partially reduce fasting glucose and improve insulin tolerance, but could not be attributed 
to an improvement in hepatic insulin signaling. 
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Magnesium is required as a cofactor in over 300 enzyme-catalyzed reactions (1). 
Magnesium functions either directly as a cofactor in the structure of enzymes, or as part 
of the Mg-adenosine triphosphate (ATP) complex. When Mg binds ATP, it partially 
shields the negative charges associated with the gamma and beta phosphoryl groups, as 
well as favorably altering the orientation of these phosphoryl groups (2). Mg is therefore 
essential for ATP hydrolysis, which is required in almost every metabolic pathway. For 
example, during the insulin signaling pathway, downstream phosphorylation reactions 
requiring Mg, such as the phosphorylation of insulin receptor and Akt, stimulate Glucose 
Transporter Type 4 (GLUT4) translocation to the cell membrane, resulting in glucose 
uptake into liver and muscle cells (2).  
The Recommended Dietary Allowance (RDA) for Mg intake in American adults 
ranges from 310 milligrams (mg) to 420mg per day. Unfortunately, many Americans 
don’t consume adequate dietary Mg. According to the 1999-2000 National Health and 
Nutrition Examination Survey (NHANES), mean daily Mg intake of the 3,510 
individuals interviewed in person was 290mg (3). Median dietary intake of Mg was lower 
than the RDA and Estimated Average Requirement (EAR) for all groups analyzed 
(except for Caucasian men aged 31 to 50 years) (3). Consistently low Mg intake can 
increase the risk of complications in a multitude of diseases, due to alterations in various 
biochemical pathways. Disease examples include cardiovascular disease, hypertension, 
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osteoporosis, and type 2 diabetes mellitus (T2D) (1). Both low Mg status (4,5) and 
consumption (6) have been associated with an increased risk for developing T2D in 
humans. Additionally, multiple studies have shown improved metabolic parameters in 
animal models fed a high Mg diet, including improved fasting glucose and insulin 
sensitivity (7,8,9). In this context, it is possible that low Mg status may impact 
phosphorylation reactions required for pathways such as insulin signaling, due to the 
integral role of the Mg-ATP complex in phosphorylation reactions. This scenario could 
lead to insulin resistance, or a worsening of insulin resistance during T2D.  
In our experiments, we utilized an established model of T2D, the TallyHo (TH) 
mouse, and compared diabetic complications in mice fed a low, normal or high Mg diets. 
We hypothesized that TH mice fed a low Mg diet would have greater metabolic 
impairments and greater insulin resistance than mice fed normal Mg diets. We also 
evaluated if diets high in Mg could improve parameters of metabolism or insulin 
signaling. We found that TH mice fed a low Mg diet have reduced energy expenditure, 




Animals and Diets 
All protocols were approved by the University of Utah Institutional Animal Care 
and Use Committee. The TallyHo (TH) polygenic mouse model (Jackson Laboratories, 
Bar Harbor, ME) was used in this study to assess the effects of dietary Mg on T2D. As 
TH mice progress from 6 to 16 weeks of age, they develop multiple characteristics 
associated with human T2D. Adults are characterized by hyperglycemia, 
hyperinsulinemia, insulin resistance, and obesity (10). Quantitative trait loci (QTL) 
Tanidd1, located on mouse chromosome 19, Tanidd2 on chromosome 13, Tanidd3 on 
chromosome 15, TallyHo-associated body weight (Tabw1) on chromosome 7, and 
TallyHo-associated fat pad (Tafat) on chromosome 6 all contribute to the hyperglycemic 
phenotype of TH mice (10).  
Four experimental groups were used in this study, each with an n = 8. The control 
group contained nondiabetic C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME), 
which were fed a standard diet of 500mg Mg per kilogram (kg) of chow, the 
recommended Mg intake for rodents in the American Institute of Nutrition (AIN) 93-M 
diet. There were 3 intervention groups, which all used the TallyHo diabetic mouse model. 
These groups were fed a low (100mg/kg chow Mg oxide), standard, or high Mg 
(1000mg/kg chow Mg bisglycinate) diet. In our previous, unpublished studies, Mg 
bisglycinate has been shown to be the most bioavailable Mg supplement. All diets were 
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formulated and purchased from Research Diets (New Brunswick, NJ, USA). 
 
Overview of Experimental Procedures 
All mice began the feeding protocol at 8 weeks old. All cages were changed daily, 
to ensure minimal fecal consumption by mice. After completing the 8-week feeding 
protocol, full body metabolism was assessed using Comprehensive Lab Animal 
Monitoring System (CLAMS). Body composition was examined using Nuclear Magnetic 
Resonance (NMR). Bone Mg status was determined by assessing bone Mg content. 
Femoral arterial dysfunction was assessed using a wire myograph. Fasting glucose, 
fasting insulin, glucose tolerance and insulin tolerance were all measured. Insulin 
signaling in liver samples was determined by measuring total and phosphorylated levels 
of Insulin receptor and Akt after either insulin or saline treatment.  
 
Nuclear Magnetic Resonance 
Using a Bruker Minispec (Billerica, MA), mice were analyzed for both grams and 
percentage of body weight constituting from fat, lean tissue, and fluid as previously 
described (11). 
 
Comprehensive Lab Animal Monitoring System (CLAMS) 
Columbus Instruments Comprehensive Lab Animal Monitoring System (CLAMS, 
Columbus Instruments, Columbus, OH) was used to measure 3-dimensional movement, 
food and water consumption, heat production, oxygen consumption, and CO2 production, 
during a 72-hour measuring period as previously described (11).   
  
5 
Glucose and Insulin Tolerance Tests 
Glucose Tolerance Tests (GTT) measured glucose clearance after an 
intraperitoneal (IP) injection of 1 milligram (mg) glucose per gram body mass. Insulin 
Tolerance Tests (ITT) measured glucose clearance after an IP injection of 0.75 units 
insulin per kilogram body mass. Mice were fasted 6 hours prior to both GTT and ITT 
experiments, and housed individually with water during the experiments. All experiments 
started at 2:30pm. 
Insulin resistance was calculated from fasting glucose and insulin concentrations 
using the homeostatic model assessment of insulin resistance (HOMA-IR) as described 
(12) using the following formula: (glucose (mg/dL) × insulin (mU/L)) / 22.5. Insulin 
sensitivity was calculated using the quantitative insulin sensitivity check index (QUICKI) 
as described (13) with the following formula: 1 / log [fasting insulin (mU/mL) + log 
(fasting glucose (mg/dL)]. 
 
Tissue Collection Protocol 
Mice were injected IP with saline or insulin (1U/kg) to stimulate activation of the 
insulin signaling pathway, then anesthetized using 3-5% isoflurane until the requisite 
plane of anesthesia was obtained. The chest cavity was opened. Cardiac puncture was 
performed to obtain a blood sample (750 ul-1000ul). Heart, gastrocnemius, and liver 
samples were taken and flash frozen in liquid N2. Tibia and fibula were saved for later 





Bone Mg Content 
Bone samples were dried and ashed at 500°C for 10 hours, after which the ash 
was dissolved in 0.2 mL concentrated HNO3 and 9.2 mL distilled water. For total Mg 
determination, tissue samples were diluted appropriately with 0.1% lanthanum chloride. 
Mg level was then calculated using flame atomic absorption spectrometry and compared 
to standard curves constructed from known Mg concentrations. 
 
Vessel Function 
Femoral arteries were taken immediately following euthanizing mice, and 
adherent tissue was removed while immersed in ice-cold dissection buffer containing 
protease and phosphatase inhibitors (14). Vessels were mounted on a wire myograph 
(BioPac Systems, Santa Barbara, CA). The vessels completed a series of internal 
circumference active tension curves to determine the vessel diameter at which the 
greatest tension development occurred (14). Following this, the vessels were subjected to 
the following conditions: phenylephrine (receptor mediated contraction), potassium 
chloride (KCl) (nonreceptor mediated contraction), acetylcholine (endothelium-
dependent vasorelaxation), and sodium nitroprusside (endothelium-independent 
vasorelaxation) (14). At least 30 minutes separated each protocol (14). 
 
Western Blots 
Proteins within liver samples were separated according to size, using sodium 
dodecyl sulfate (SDS) polyacrylamide gel electrophoresis. Using Turbo Transfer 
(BioRad, Hercules, CA), proteins were transferred to nitrocellulose membranes. 
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Membranes were blocked for one hour at room temperature, using Licor blocking buffer 
(Licor Biosciences, Lincoln, NE), to prevent nonspecific binding of primary and/or 
secondary antibodies. Membranes were then incubated with primary antibodies directed 
against phosphorylated and total Insulin receptor ( subunit, tyrosine 1361) and Akt 
(serine 473), in Licor blocking buffer overnight at 4C (1:1000 dilution). Next, 
membranes were washed three times with 0.1% PBS-T, at five minutes per wash and then 
incubated with secondary antibody (Licor Biosciences, Lincoln, NE) at a 1:5000 dilution 
in Licor blocking buffer for one hour in an ultraviolet-protected container. Following 3 
washes with 0.1% PBS-T, membranes were imaged using a Licor Odyssey infrared 
scanner (Lincoln, NE) to quantify band densities. All primary antibodies were purchased 
from Cell Signaling Technology (Beverly, MA).  
 
Data Analysis 
Data are reported as means +/- standard error. Data were analyzed via one-way 
ANOVA for all measurements, except for vessel function and Western Blots. Tukey’s 
post hoc test was used to detect differences between groups. Vessel function was 
analyzed via repeated measures ANOVA.  Western Blots were analyzed using ANOVA 
for saline-treated mice and insulin-treated mice as independent groups. Tukey’s post-hoc 
test was then used to detect differences between groups if main effects were detected. 





All diabetic groups, especially mice fed the low Mg diet, had lower bone Mg 
concentrations versus mice in the control group. Additionally, there was a strong trend 
for TH mice fed the low Mg diet to have lower bone Mg, compared to the TH mice fed 
the standard (p = 0.066) or high (p = 0.069) Mg diets (Figure 1). 
 
Final Body Weight and Composition 
All TH mice, regardless of their diet, had significantly higher body mass, higher 
fat mass, and lower lean mass, compared with the control mice fed the standard diet 
(Figure 2A, B, C). 
 
Oxygen Consumption and Energy Expenditure 
Mice fed the low Mg diet had the lowest oxygen consumption, while mice fed the 
standard and high Mg diets had similar oxygen consumption to the control mice (Figure 
3A). There were no significant differences observed in carbon dioxide production 
between any of the experimental groups (Figure 3B). Mice fed the low Mg diet had the 
highest respiratory exchange ratio, while mice fed the standard and high Mg diets were 
similar to the control mice (Figure 3D). 
Mice fed the low Mg diet also had the lowest energy expenditure, while levels 
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were unchanged across all other groups (Figure 3E). Finally, mice fed the low and 
standard Mg diets were the most sedentary according to beam break counts, while mice 




Fasting hyperglycemia was observed in mice fed the low and standard Mg diets. 
Additionally, there was a partial improvement in fasting glucose in the mice fed the high 
Mg diet towards the control group fasting glucose concentration (Figure 4A). 
Conversely, fasting insulin levels remained high in all diabetic mouse groups, compared 
to the control group (Figure 4B). Glucose tolerance was significantly worse in all 
diabetic mouse groups, versus mice fed the control diet (Figure 4C). Insulin tolerance 
was significantly worse in mice fed the low and standard Mg diet, indicating insulin 
resistance. There was also a partial recovery of insulin tolerance in mice fed the high Mg 
diet bringing it more in line with the control group level (Figure 4D). 
All diabetic mouse groups had lower insulin sensitivity as calculated by QUICKI 
index versus the control group (Figure 4E). Mice on the low Mg diet were found to have 
the least insulin sensitivity. Insulin resistance was estimated using HOMA-IR index, and 
mice fed the low and high Mg diets had greater insulin resistance than controls, while the 
standard Mg diet group was similar to both the high Mg and the control groups (Figure 






All vessel characteristics were nonsignificant. (Table 1). No difference was noted 
between any of the femoral arteries when assessing endothelium-dependent 
vasorelaxation (Figure 5A), endothelium-independent vasorelaxation (Figure 5B), or 
receptor-mediated vasocontraction (Figure 5C). A significantly greater nonreceptor 
mediated contraction was seen in the femoral arteries of the control group versus all three 
diabetic groups, at concentrations of 60, 80, and 100 millimolar KCl (Figure 5D). 
 
Western Blots 
Insulin-stimulated phosphorylation of IR was similar across all groups (Figure 6). 
Insulin-stimulated phosphorylation of Akt was significantly blunted in all TH mice 




Table 1. Characteristics of vessels from vessel function experiments. 
  
Start Width (µm) End Width (µm) Vessel Length (µm) PE % change 
TH 100 MgO 165.6 +/- 8.1 493.8 +/- 7.8 1975.0 +/- 18.9 0.69 +/- 0.05 
TH 500 MgO 181.3 +/- 10.3 478.1 +/- 8.8 1906.3 +/- 41.7 0.65 +/- 0.05 
TH 1000 MgBG 189.4 +/- 12.4 475.0 +/- 10.6 1964.4 +/- 30.9 0.66 +/- 0.03 
C57 500 MgO 175.0 +/- 8.2 503.1 +/- 8.8 1843.8 +/- 57.0 0.70 +/- 0.02 
 
Note. * P < 0.05 corrected model test - between-subjects’ effects. PE % change refers to 
the extent of the phenylephrine-induced precontractile forces of the femoral arteries prior 
to the acetylcholine curve measurements. Data represented as mean +/- standard error for 
n = 8 per group. TH 100 MgO (TallyHo, 100mg Mg Oxide/kg chow), TH 500 MgO 
(TallyHo, 500mg Mg Oxide/kg chow), TH 1000 MgBG (TallyHo, 1000mg Mg 





Figure 1. Bone Mg concentrations, measured in milligrams per gram, for the 3 diabetic 
mouse groups and the control group. Data represented as mean +/- standard error for n = 
8 per group. Significant difference (P < 0.05) is noted using nonsimilar letters. TH L-Mg 
(TallyHo, 100mg Mg Oxide/kg chow), TH S-Mg (TallyHo, 500mg Mg Oxide/kg chow), 






Figure 2. Body composition assessment for the 3 diabetic mouse groups and the control 
group. (A) Body mass, measured in grams; (B) lean mass, as a percentage of body weight 
and (C) fat mass, also as a percentage of body weight, for the 3 diabetic mouse groups, 
and the control group. Data represented as mean +/- standard error for n = 8 per group. 
Significant difference (P < 0.05) is noted using nonsimilar letters. TH L-Mg (TallyHo, 
100mg Mg Oxide/kg chow), TH S-Mg (TallyHo, 500mg Mg Oxide/kg chow), TH H-Mg 





Figure 3. Measurements taken using CLAMS for the 3 diabetic mouse groups and the 
control group. (A) Volume of oxygen inhaled, measured in milliliters per kilogram body 
weight per hour; (B) volume of carbon dioxide expired, measured in milliliters per 
kilogram body weight per hour; (C) physical activity of mice through x, y, and z axis, 
measured by beam breaks per 48 hours; (D) 48-hour energy expenditure, measured by 
calories per hour per gram body weight; and (E) 48-hour respiratory exchange ratio. Data 
represented as mean +/- standard error for n = 8 per group. Significant difference (P < 
0.05) is noted using nonsimilar letters. TH L-Mg (TallyHo, 100mg Mg Oxide/kg chow), 
TH S-Mg (TallyHo, 500mg Mg Oxide/kg chow), TH H-Mg (TallyHo, 1000mg Mg 




Figure 4. Insulin sensitivity measurements for the 3 diabetic mouse groups and the 
control group. (A) Fasting serum glucose, measured in milligrams per deciliter; (B) 
fasting serum insulin, measured in nanograms per deciliter; (C) Insulin Tolerance Test 
Area Under the Curve; (D) Homeostatic Model Assessment of Insulin Resistance; (E) 
Quantitative Insulin Sensitivity Check Index; and (F) Glucose Tolerance Test Area Under 
the Curve. Data represented as mean +/- standard error for n = 8 per group. Significant 
difference (P < 0.05) is noted using nonsimilar letters. TH L-Mg (TallyHo, 100mg Mg 
Oxide/kg chow), TH S-Mg (TallyHo, 500mg Mg Oxide/kg chow), TH H-Mg (TallyHo, 




Figure 5. Vessel function curves for the 3 diabetic mouse groups and the control group. 
(A) Endothelium-dependent vasorelaxation of the femoral artery, using acetylcholine; (B) 
Endothelium-independent vasorelaxation, using sodium nitroprusside; (C) Receptor-
mediated vasocontraction, using phenylephrine; and (D) Nonreceptor mediated 
vasocontraction, using potassium chloride. * P < 0.05 vs. Control Mg. Data represented 
as mean +/- standard error for n = 8 per group. TH 100 MgO (TallyHo, 100mg Mg 
Oxide/kg chow), TH 500 MgO (TallyHo, 500mg Mg Oxide/kg chow), TH 1000 MgBG 






Figure 6.  Phospho-Insulin Receptor (p-IR), IR, Phospho-Akt (p-Akt), and Akt 
concentrations in liver tissue samples between saline and insulin-stimulated mice. *P < 
0.05 versus saline-treated mice. Data represented as mean +/- standard error for n = 4 per 
group. L-Mg (TallyHo, 100mg Mg Oxide/kg chow), S-Mg (TallyHo, 500mg Mg 
Oxide/kg chow), H-Mg (TallyHo, 1000mg Mg Bisglycinate/kg chow), Con (C57BL/6J, 








Our study reports for the first time that a low Mg diet fed to TallyHo diabetic 
mice resulted in reduced energy expenditure, and further exacerbated hyperglycemia and 
insulin sensitivity. We conclude that a low Mg diet worsens metabolic parameters 
associated with T2D. Additionally, a high Mg diet of 1000 milligrams Mg per kilogram 
of chow does not improve diabetic complications in TH mice beyond the level seen in 
those fed a standard diet. 
Type 2 diabetics often exhibit decreased Mg status, due to increased urinary 
excretion of Mg (15). At reduced plasma concentrations, Mg is rapidly released from the 
bone. While all TH mice had lower bone Mg content than controls, TH mice fed low Mg 
diets had significantly lower bone Mg concentrations. Increasing dietary Mg content 
blunted Mg loss as evidenced by a strong trend toward greater bone Mg for diabetic 
groups fed the standard and high Mg diets versus those on low Mg diet. Mice fed low Mg 
may have had increased bone resorption of Mg compared to the other groups. However, a 
limitation of our study was that we did not measure urine Mg content, and therefore could 
not confirm that TH mice lost more Mg in their urine.  
Mg status does not appear to affect endothelium-dependent or endothelium-
independent vessel function, as no significant differences were noted between groups for 
either mechanism being assessed. Significantly greater nonreceptor mediated contractions 
were noted in the femoral arteries of the control mice, compared to the TH mice. 
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Nonreceptor mediated contractions result from potassium chloride stimulation of the 
femoral arteries. Potassium chloride directly activates volatge-gated calcium channels, 
causing smooth muscle contraction. Conversely, during receptor-mediated contraction, 
smooth muscle contraction is initiated by adrenergic alpha-1 receptor, for which 
phenylephrine is an agonist.  Phenylephrine stimulation results in the conversion of 
phosphatidylinositol (3,4,5)-trisphosphate (PIP3) to inositol triphosphate (IP3) and 
diacylglycerol (DAG). IP3 is responsible for an increase in cellular calcium, resulting in 
contraction (16). The significant differences observed between control and TH mice 
suggests that diabetic phenotypes may worsen nonreceptor mediated contraction of 
femoral arteries, and that Mg intake does not play a role in the degree of vascular 
dysfunction observed in this model of diabetes. It has been previously theorized that 
TallyHo mice exhibit smooth muscle contraction dysfunction, due to oxidative stress and 
enhanced Rho kinase activity affecting receptor-mediated contraction (17). However, this 
theory is not applicable to our findings, which saw dysfunction in nonreceptor mediated 
contraction.  
Kobayashi et al. found a strong negative correlation between Mg status and 
oxygen consumption in human NIDDM subjects (18), but did not report a mechanistic 
rationale for this relationship. The observation is consistent with our finding that TH mice 
fed the low Mg diet also had significantly lower oxygen consumption, while TH mice fed 
adequate Mg were comparable to the control group. The mechanism for this is unclear 
but there are two possible explanations: i) since oxygen consumption represents physical 
work capacity (18), diminished oxygen consumption may have been due to a reduction in 
physical activity; or ii) impaired oxygen delivery to muscle could have reduced the 
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capacity for physical activity since Mg is required for enzymatic reactions involved in 
oxygen delivery (19). Both energy expenditure and physical activity, however, did not 
affect overall body weight of low Mg fed TH mice since body mass of all TH mice were 
similar and comparable to previously documented weights (20). 
Metabolic chamber assessment indicated that TH mice fed the low Mg diet had 
the highest respiratory exchange ratio (RER), whilst other TH mice were comparable to 
the control group. A higher RER indicates carbohydrates are the predominant energy 
source being utilized, whereas a lower RER suggests lipids are the main energy source 
(21). The RER data however, contrasts with our finding that TH mice fed the low Mg diet 
had greater insulin resistance and fasting glucose than the other diabetic groups. 
Theoretically, greater insulin resistance should favor more reliance on lipid oxidation. 
Given this apparent contradiction, it is possible the reduced oxygen consumption 
measured in the low Mg fed mice could lead to a higher RER value since RER is 
calculated as a ratio of volume of oxygen consumed to volume of carbon dioxide 
produced. 
Our general findings regarding fasting insulin and glucose homeostasis are 
consistent with the previously documented phenotypes of the TallyHo mouse model (20). 
Kim et al. found TH mice to have impaired glucose tolerance and hyperinsulinemia by 8-
weeks of age and postulated that the presence of both glucose intolerance and 
hyperinsulinemia in TH mice results from a compensatory hypersecretion mechanism, 
due to diminished peripheral insulin action (20). Our data also demonstrate that dietary 
Mg may influence the TH phenotype. For example, we found that fasting glucose was 
highest in TH mice fed low and standard Mg, but partially normalized in high Mg fed TH 
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such that their glucose levels were in between those of controls and the other TH groups. 
Similarly, indices of both insulin resistance (HOMA) and insulin sensitivity (QUICKI), 
were improved in TH mice fed high Mg diets versus low Mg diets as well, providing 
further evidence for the integral role of Mg for normal metabolism.  
Our data regarding insulin resistance agrees with previous studies in both animals 
and humans that associate a low Mg diet with increased likelihood of insulin resistance 
(15). Currently, there are no proven mechanistic explanations for this association. We 
hypothesized that low Mg status could directly affect insulin receptor phosphorylation. 
Crystal structures of the insulin receptor have shown two Mg ions bind to the tyrosine 
kinase domain, in order to increase tyrosine kinase affinity for ATP molecules, thus 
improving kinase activity (22). In previous studies, mice exhibiting hypomagnesemia 
were found to have reduced levels of phosphorylated insulin receptor in both cardiac and 
skeletal muscle tissue, giving rise to an insulin resistant phenotype (22). While the 
aforementioned research supports the idea that hypomagnesemia may worsen insulin 
resistance in TH mice, molecular evidence from our study found no alteration at the level 
of the insulin receptor in liver. Specifically, we observed that insulin-stimulated 
phosphorylation of the insulin receptor in the liver was similar across all control and TH 
groups. In contrast to the lack of change in hepatic insulin receptor, insulin-stimulated p-
Akt : Akt was significantly blunted in all diabetic TH mice versus control mice. 
However, similarity of p-Akt : Akt in the liver did not reflect the fact that low Mg-fed TH 
mice have greater whole body insulin resistance compared to high Mg-fed TH mice 
according to HOMA-IR and QUICKI. Given this paradox, it is possible that other tissues 
such as skeletal muscle may have changes in insulin-stimulated signaling under high 
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dietary Mg conditions that could account for the whole body differences reflected in the 
fasting glucose levels and QUICKI/HOMA-IR indices. On-going studies are testing this 
hypothesis. 
In conclusion, TH mice fed a low Mg diet resulted in reduced energy expenditure, 
and further exacerbated insulin resistance, and hyperglycemia. The possible molecular 
culprits for exacerbated insulin resistance in hypomagnesemic TH mice warrant further 
exploration. These findings also have clinical implications. Mean US adult Mg intake is 
suboptimal (15). Additionally, diabetic patients are already susceptible to low Mg status 
(1). Chutia and Lynrah observed serum Mg decreases with increased insulin resistance in 
T2D patients (4), while Mooren found Mg intake is significantly inversely associated 
with the risk of T2D in a dose-dependent manner (8). Evidence from our study leads us to 
speculate that diabetic individuals with low Mg intake may be worsening their condition. 
While our data did not clearly indicate that a high Mg diet provides a beneficial effect on 
diabetic vascular complications, we did find evidence that the level of dietary Mg can 
positively impact various parameters of insulin function. Data from our study supports 
the concept of Mg supplementation in both prediabetic and diabetic individuals, which 




1. Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus, 
metabolic syndrome and insulin resistance. Arch. Biochem. Biophys. 2007;458:40-7. 
 
2. Nelson DL, Cox MM. Lehninger Principles of Biochemistry. WH Freeman and 
Company; 2008. 
 
3. Ford ES, Mokdad AH. Dietary magnesium intake in a national sample of US adults. 
J. Nutr. 2003;133(9):2879-82. 
 
4. Chutia H, Lynrah KG. Association of serum magnesium deficiency with insulin 
resistance in type 2 diabetes mellitus. J Lab Physicians. 2015;7(2):75-8. 
 
5. Chaudhary DP, Sharma R, Bansal DD. Implications of magnesium deficiency in type 
2 diabetes: a review. Biol Trace Elem Res. 2010;134(2):119-29. 
 
6. Dong JY, Xun P, He K, Qin LQ. Magnesium intake and risk of type 2 diabetes: meta-
analysis of prospective cohort studies. Diabetes Care. 2011;34(9):2116-22. 
 
7. Solati M, Ouspid E, Hosseini S, Soltani N, Keshavarz M, Dehghani M. Oral 
magnesium supplementation in type II diabetic patients. Med J Islam Repub Iran. 
2014;28:67. 
 
8. Mooren FC. Magnesium and disturbances in carbohydrate metabolism. Diabetes 
Obes. Metab. 2015;17:813-823. 
 
9. Balon TW, Gu JL, Tokuyama Y, Jasman AP, Nadler JL. Magnesium supplementation 
reduces development of diabetes in a rat model of spontaneous NIDDM. Am J 
Physiol. 1995;269:745-752. 
 
10. TALLYHO/JNGJ: A polygenic mouse model of type 2 diabetes [Internet]. The 




11. Boudina S, Sena S, Sloan C, Tebbi A, Han YH, O’Neill BT, Cooksey RC, Jones D, 
Holland WL, McClain DA, et al. Early mitochondrial adaptations in skeletal 
  
24 
muscle to diet-induced obesity are strain dependent and determine oxidative stress 
and energy expenditure but not insulin sensitivity. Endocrinology. 2012;156(6):2677-
2688. 
 
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 
Homeostasis model assessment: insulin resistance and beta-cell function from fasting 
plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9. 
 
13. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. 
Quantitative insulin sensitivity check index: a simple, accurate method for assessing 
insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402-10. 
 
14. Park SY, Rossman MJ, Gifford JR, Bharath LP, Bauersachs J, Richardson RS, Abel 
ED, Symons JD, Riehle C. Exercise training improves vascular mitochondrial 
function. Am J Physiol Heart Circ Physiol. 2016;310(7):821-829. 
 
15. Barbagallo M, Dominguez LJ. Magnesium and type 2 diabetes. World J Diabetes. 
2015;6(10):1152-1157. 
 
16. Gonzales RJ, Carter RW, Kanagy NL. Laboratory demonstration of vascular smooth 
muscle function using rat aortic ring segments. Adv Physiol Educ. 2000;24(1):13-21. 
 
17. Didion SP, Lynch CM, Faraci FM. Cerebral vascular dysfunction in TallyHo mice: a 
new model of Type II diabetes. Am J Physiol Heart Circ Physiol. 2007;292(3):1579-
83. 
 
18. Kobayashi T. Plasma and erythrocyte magnesium levels are correlated with oxygen 
uptake in patients with non-insulin dependent diabetes mellitus. Endocr J. 
1998;45(2):277-83. 
 
19. Lukaski HC, Bolonchuk WW, Klevay LM, Milne DB, Sandstead HH. Maximal 
oxygen consumption as related to magnesium, copper, and zinc nutriture. Am J Clin 
Nutr. 1983;37(3):407-15. 
 
20. Kim JH, Stewart TP, Soltani-Bejnood M, Wang L, Fortuna JM, Mostafa 
OA, Moustaid-Moussa N, Shoieb AM, McEntee MF, Wang Y, et al. Phenotypic 
characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice. J 
Endocrinol. 2006;191(2):437-446. 
 
21. Ramos-Jiménez, A., Hernández-Torres, R. P., Torres-Durán, P. V., Romero-
Gonzalez, J., Mascher, D., Posadas-Romero, C., Juárez-Oropeza, M. A. The 
respiratory exchange ratio is associated with fitness indicators both in trained and 
untrained men: a possible application for people with reduced exercise tolerance. Clin 





22. Gommers LM, Hoenderop JG, Bindels RJ, de Baaij JH. Hypomagnesemia in type 2 
diabetes: a vicious circle? Diabetes. 2016;65(1):3-13. 
